Mengdi Zhu

LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

Qianfeng Shi, Yudong Li, Shunying Li et al. · Nature Communications · 2020 · 194 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

Zijie Cai, Jingru Wang, Yudong Li et al. · Science China Life Sciences · 2022 · 106 citations

Medicine, Cancer Biology, Oncology +17

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy

Shunying Li, Hongna Lai, Jieqiong Liu et al. · JCO Precision Oncology · 2020 · 75 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Comparative evaluation of label-free quantification strategies

Lei Zhao, Xiaoji Cong, Linhui Zhai et al. · Journal of Proteomics · 2020 · 74 citations

Language Studies, Mathematics, Computational Linguistics +11

Hypermongones A–J, Rare Methylated Polycyclic Polyprenylated Acylphloroglucinols from the Flowers of <i>Hypericum monogynum</i>

Wen‐Jun Xu, Mengdi Zhu, Xiaobing Wang et al. · Journal of Natural Products · 2015 · 51 citations

Natural Sciences, Botany, Chemistry +12